Results 231 to 240 of about 5,237,827 (280)

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

Girls just wanna have funds: a new Transparent Reporting Scale for evaluating grant data reporting from funding agencies. [PDF]

open access: yesFront Comput Neurosci
Clarke N   +9 more
europepmc   +1 more source

Examining disparities in harmful reporting on community firearm violence in Philadelphia television news reports. [PDF]

open access: yesInj Epidemiol
Beard JH   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy